Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
GeneSegues
Download detailed PDF Members: GeneSegues is a biopharmaceutical company built upon advanced, targeted drug delivery technology. We conduct research and early-stage development of proprietary oncology biopharmaceuticals using our ligand-directed, nanoencapsulation technology. Our two initial product candidates are antisense therapeutics for treatment of advanced head neck and prostate cancers. We are currently conducting animal experiments with our lead product candidate for head neck cancer, and in vitro experiments with our product candidate for prostate cancer. As we progress, we will seek to outlicense these therapeutic candidates to larger drug companies for later-stage development and post-approval marketing.
This page has been viewed 361 times since April 2007, the link to the organisation's website has been followed 76 times Recent Search Terms used to find this page: genesegues | genesegues | genesegues | nanoencapsulation Genesegues | . This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for GeneSegues | ||||||||||||||||||||||||||
|